Innovation
iprob ® and iproboro® are innovative probiotics specific adjuvants for the therapy of allergic diseases
MADE UP OF A SYNERGIC ASSOCIATION OF THREE SPECIES OF LACTOBACILLUS ADJUVED WITH STREPTOCOCCUS THERMOPHILUS
THE MAIN FEATURES OF iprob ® ARE:
-
Innovative production processes
-
Preservation of probiotic properties even outside the fridge up to 25 ° C
-
Use of bacterial strains with adjuvant action:
-
L. Acidophilus LA02 , L. Delbrueckii LDB01, L. Rhamnosus LR04, Streptococcus Thermophilus FP04
-
Absence of lactose, egg proteins and gluten in the culture medium
-
Absence of flavorings
-
Use of fructose as a sweetener
-
These particular requirements make iprob® an ideal adjuvant for people who are allergic or intolerant to food, as well as diabetics.
|
TO WHOM IT IS RECOMMENDED :
-
In atopy, including forms characterized by subsequent episodes of febrile infectious disease
-
In the intrinsic forms of allergy and intolerance, in which the inflammation is substantially cellular and the specific IgEs are not yet detectable
-
In the classic extrinsic forms of allergy, in bad responders to allergen-specific immunotherapy